Clinically Integrated Networks: A Growing Disrupter in American Healthcare

Publish date: 19 Jun, 2019

Download Now





This live session took place on June 13th, 2019

Clinically Integrated Networks are vehicles for powerful IDNs to extend their influence into the physician sector and play a key role for IDNs trying to pave a path to becoming a self-contained healthcare ecosystem. Of the 200 state-level IDNs profiled, nearly two-thirds had CINs.

CINs are becoming the primary point of engagement for IDNs and are becoming more crucial to population health management and value-based contracts. To this end, CINs are the foundation for value-based narrow provider networks.

There are many types of IDNs, from major powerhouses within local markets to Academic medical centers, payer/provider networks and other unique arrangements.

Specifically, this webinar covered:

  • What CINs are
  • What makes CINs different from other physician organizations
  • Their role in the overall IDN ecosystem
  • Types of IDNs with specific case studies
  • Implications and strategies for pharma

Presenters:

  • Mark Cherry, Principal Analyst with Market Access
  • Valerie E. Pillo, Senior Analyst with Market Access





Healthbase


The rapid growth and consolidation of IDNs are having a profound impact the delivery of care at both the national and regional levels. This includes greater control on HCP decisions, rising competition with traditional insurers and pharmacies as well as a greater emphasis on value based care.
Can you identify key stakeholder alignments at the local level?

Healthbase has been built to provide multi-disciplinary market access teams with the data and insight they need to understand alignments between systems – down to the individual provider level – and ascertain the market control of IDNs across US regions and patient populations.

Learn more or schedule a demo today.

Learn More

Will Netflix-Style Payment Models be the New Norm For High Cost Drugs?

NEXT ARTICLE